Condition: Spinal Cord Injury · Sponsor: NeuroXess Technology (shanghai) Co.,Ltd.
This prospective, multicenter, single-arm clinical trial will enroll subjects with tetraplegia secondary to spinal cord injury. An implantable brain-computer interface system for compensatory hand motor function will be used to reconstruct upper-limb function, so as to evaluate the safety and clinical efficacy of this device in achieving upper-limb functional replacement.
This description comes directly from the study's public registry record.
Ying Mao, MD · +86 021 5288 8045 · maoying@fudan.edu.cn
Liang Chen, MD · hschenliang@fudan.edu.cn
Always discuss trial participation with your own doctor first.
| Huashan Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07720882